FLUDARA 50 mg, powder for solution for injection or infusion 5 bottles of 10 ml
Active ingredients: PHOSPHATE DE FLUDARABINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion5 bottles of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLUDARA 50 mg, poudre pour solution injectable ou perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- GENZYME EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61324127CIP75585442CIP133400955854425Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DE FLUDARABINEpoudre | 50 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.